Bioventus (BVS) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Bioventus (BVS) has outperformed Tandem Diabetes Care (TNDM) over the past year, gaining 92.0% versus a gain of 9.1%. Over five years, BVS leads with a -6.4% price change compared with -87.4% for TNDM. Tandem Diabetes Care is the larger company by market cap ($1.10 billion vs $872.3 million), about 1.3 times the size.
On valuation, Bioventus trades at a lower forward P/E (13.9x vs 99.6x for Tandem Diabetes Care).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BVS | TNDM |
|---|---|---|
| Share price | $12.77 | $15.84 |
| Market cap | $872.26M | $1.10B |
| 1-day change | -2.52% | -1.98% |
| YTD return | +71.64% | -27.93% |
| 1-year return | +92.03% | +9.09% |
| 5-year return | -6.38% | -87.36% |
| P/E ratio (TTM) | 16.80 | — |
| Forward P/E | 13.88 | 99.65 |
| EPS (TTM) | $0.76 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.89 | $29.65 |
| 52-week low | $6.37 | $12.26 |
| Distance from 52-week high | -19.65% | -46.58% |
| Average volume | 623.67K | 1.98M |
| Shares outstanding | 68.31M | 69.58M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BVS has outperformed TNDM by 82.9 percentage points over the past year.
BVS vs TNDM FAQ
Which is bigger, Bioventus or Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.10B compared with $872.26M for Bioventus (BVS).
Which stock has performed better over the past year, BVS or TNDM?
BVS returned +92.03% over the past 12 months, compared with +9.09% for TNDM (price return, excluding dividends). Past performance does not predict future results.
Are Bioventus and Tandem Diabetes Care in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.